- Title :
- Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
- Index Terms :
-
Sciences bio-médicales et agricoles
Aged
Antineoplastic Agents -- administration & dosage -- adverse effects
Aromatase Inhibitors -- administration & dosage -- adverse effectsBiomarkers ,Tumor --analysis
Breast Neoplasms -- chemistry -- drug therapy -- mortality -- pathology
Chemotherapy, Adjuvant
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Letrozole
Middle Aged
Nitriles -- administration & dosage -- adverse effects
Postmenopause
Receptor, ErbB-2 --analysis
Receptors, Estrogen --analysis
Receptors, Progesterone --analysis
Time Factors
Treatment Outcome
Triazoles -- administration & dosage -- adverse effects
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article - URL :
-
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290445">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290445 http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL -
Electronic Resource